OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Barriers and opportunities in pancreatic cancer immunotherapy
Yixin Ju, Dongzhi Xu, Miao-Miao Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Mast cells: key players in digestive system tumors and their interactions with immune cells
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1

Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 6

The multi-faceted roles of cancer-associated fibroblasts in pancreatic cancer
John Y. Kwon, Renzo E. Vera, Martín E. Fernández-Zapico
Cellular Signalling (2025) Vol. 127, pp. 111584-111584
Open Access

NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
Youlong Zhu, Zongze Qi, Sean KONG. Yao Zu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access

Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy
Alicia Arroyo-Nogales, Guillermo Plaza-Palomo, Javier Gónzalez‐Larre, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1257-1257
Open Access

Stromal Fibrin Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Mazharul Karim, Md. Mahedi Hasan, Seung Hyun Kim, et al.
Biomaterials (2025), pp. 123280-123280
Closed Access

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer
Juliana Calheiros, Rita Silva, Filipa Barbosa, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation
Soyeon Yi, Kyunghee Noh, Hye-Ran Kim, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer
Sreejith Thrivikraman Nair, C Abhi, Kaladhar Kamalasanan, et al.
Molecular Pharmaceutics (2024)
Closed Access

Page 1

Scroll to top